EA201300134A1 - PHARMACEUTICAL COMPOSITION AND METHOD FOR THE TREATMENT AND PREVENTION OF DISEASES CAUSED OR CONNECTED WITH HIV - Google Patents

PHARMACEUTICAL COMPOSITION AND METHOD FOR THE TREATMENT AND PREVENTION OF DISEASES CAUSED OR CONNECTED WITH HIV

Info

Publication number
EA201300134A1
EA201300134A1 EA201300134A EA201300134A EA201300134A1 EA 201300134 A1 EA201300134 A1 EA 201300134A1 EA 201300134 A EA201300134 A EA 201300134A EA 201300134 A EA201300134 A EA 201300134A EA 201300134 A1 EA201300134 A1 EA 201300134A1
Authority
EA
Eurasian Patent Office
Prior art keywords
prevention
treatment
pharmaceutical composition
diseases caused
hiv
Prior art date
Application number
EA201300134A
Other languages
Russian (ru)
Other versions
EA032021B1 (en
Inventor
Олег Ильич ЭПШТЕЙН
Сергей Александрович ТАРАСОВ
Original Assignee
Олег Ильич ЭПШТЕЙН
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Олег Ильич ЭПШТЕЙН filed Critical Олег Ильич ЭПШТЕЙН
Publication of EA201300134A1 publication Critical patent/EA201300134A1/en
Publication of EA032021B1 publication Critical patent/EA032021B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2812—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against CD4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0004—Homeopathy; Vitalisation; Resonance; Dynamisation, e.g. esoteric applications; Oxygenation of blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Настоящее изобретение относится к фармацевтической композиции, содержащей активированно-потенцированную форму антител к CD4 рецептору, и способу лечения и профилактики заболеваний, вызванных или связанных с ВИЧ-инфекцией, включая СПИД.The present invention relates to a pharmaceutical composition comprising an activated-potentiated form of antibodies to the CD4 receptor, and a method for the treatment and prevention of diseases caused or associated with HIV infection, including AIDS.

EA201300134A 2010-08-06 2011-07-15 Pharmaceutical composition and method of treating and preventing the diseases caused by hiv and/or associated with hiv EA032021B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
RU2010133049/15A RU2010133049A (en) 2010-08-06 2010-08-06 MEDICINAL PRODUCT AND METHOD FOR PREVENTION OF HIV INFECTION, PREVENTION AND TREATMENT OF DISEASES CAUSED BY HIV OR ASSOCIATED WITH HIV, INCLUDING AIDS
PCT/IB2011/002469 WO2012017327A2 (en) 2010-08-06 2011-07-15 Pharmaceutical composition and methods of treating and preventing the diseases caused by hiv or associated with hiv

Publications (2)

Publication Number Publication Date
EA201300134A1 true EA201300134A1 (en) 2014-03-31
EA032021B1 EA032021B1 (en) 2019-03-29

Family

ID=44906251

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201300134A EA032021B1 (en) 2010-08-06 2011-07-15 Pharmaceutical composition and method of treating and preventing the diseases caused by hiv and/or associated with hiv

Country Status (5)

Country Link
EA (1) EA032021B1 (en)
FR (1) FR2963562A1 (en)
RU (1) RU2010133049A (en)
UA (1) UA113389C2 (en)
WO (1) WO2012017327A2 (en)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4311897A (en) 1979-08-28 1982-01-19 Union Carbide Corporation Plasma arc torch and nozzle assembly
RU2181297C2 (en) * 2000-06-20 2002-04-20 Эпштейн Олег Ильич Method of treatment of pathological syndrome and medicinal agent
RU2192888C1 (en) 2001-02-15 2002-11-20 Эпштейн Олег Ильич Medicinal agent and method of treatment of pathological syndrome
RU2001134982A (en) * 2001-12-26 2004-02-20 Олег Ильич Эпштейн METHOD OF IMMUNE RESPONSE CORRECTION AND MEDICINE
UA76641C2 (en) 2002-08-02 2006-08-15 Олєг Ільіч Епштєйн Homeopathic medicinal agent and method for curing diseases of prostate
UA76638C2 (en) 2002-08-02 2006-08-15 Oleh Illich Epshtein Homeopathic medication based on anti-interferon antibodies and method for treating a pathological syndrome associated with interferon
WO2004082597A2 (en) 2003-03-14 2004-09-30 Nutrition Research, Inc. Homeopathic formulations useful for treating pain and/or inflammmation

Also Published As

Publication number Publication date
FR2963562A1 (en) 2012-02-10
RU2010133049A (en) 2012-02-20
WO2012017327A3 (en) 2012-04-12
UA113389C2 (en) 2017-01-25
EA032021B1 (en) 2019-03-29
WO2012017327A2 (en) 2012-02-09

Similar Documents

Publication Publication Date Title
CY1124043T1 (en) HUMAN IMMUNODEFICIENCY VIRUS-NEUTRALIZING ANTIBODIES AND METHODS OF USING THEM
EA201891186A1 (en) ANTIBODIES, NEUTRALIZING THE VIRUS OF HUMAN IMMUNODEFICIENCY
EA201170396A1 (en) 2-OXO-1,2-dihydroquinoline modulators of immune function
EA201391719A1 (en) HINASOLINE DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS AND FURTHER DISEASES
EA201300132A1 (en) PHARMACEUTICAL COMPOSITION AND METHODS OF TREATMENT AND PREVENTION OF DISEASES CAUSED BY HIV OR ASSOCIATED WITH HIV
EA201590343A1 (en) ALKYLPYRIMIDINE DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS AND FURTHER DISEASES
EA201992133A1 (en) PIPERIDINO-PYRIMIDINE DERIVATIVES FOR TREATMENT OF VIRAL INFECTIONS
EA201390060A1 (en) ANNELED PYRIMIDINES AND TRIAZINES AND THEIR APPLICATION FOR THE TREATMENT AND / OR PREVENTION OF CARDIOVASCULAR DISEASES
EA201590358A1 (en) Inhibitors of Human Immunodeficiency Virus Replication
EA201590667A1 (en) ACYLAMINOPYRIMIDINE DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS AND OTHER DISEASES
EA201500383A1 (en) DERIVATIVES 1,2,4-TRIAZINE FOR THE TREATMENT OF VIRAL INFECTIONS
UA116999C2 (en) Anti-hemagglutinin antibodies and methods of use
EA201690520A1 (en) METHOD OF OBTAINING SUBSTITUTED 5-FLUOR-1H-PYRAZOLOPIRIDINES
EA201300137A1 (en) COMBINED PHARMACEUTICAL COMPOSITION AND METHOD FOR THE TREATMENT OF DISEASES OR CONDITIONS ASSOCIATED WITH NEURODEGENERATIVE DISEASES
MX347734B (en) S100a4 antibodies and therapeutic uses thereof.
EA201400623A1 (en) NEW 2H-INDASOLS AS ANTAGONISTS EP EPCEPTOR
EA201290956A1 (en) VACCINE AGAINST HIV
EA201300034A1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING IMATINIB OR ITS PHARMACEUTICALLY ACCEPTABLE SALT, AND WAYS TO OBTAIN THEM
SG179082A1 (en) Method for the preparation of an influenza virus
MA35816B1 (en) Aniline derivatives, their preparation and their therapeutic application
EP2601967A4 (en) Drug and method for the prophylaxis of hiv infection and for the prophylaxis and treatment of diseases caused by or associated with hiv, including aids
EA201291211A1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING HYDROMORPHONE AND NALOXONE
WO2012047267A3 (en) Polyvalent immunogen
EP2588121A4 (en) Analogs of c5a and methods of using same
GB201303865D0 (en) Pharmaceutical composition and method of inhibiting of production or amplifyingelimination of P24 protein

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU